ICL Confidence in Concept 2013
Lead Research Organisation:
Imperial College London
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding. It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.
Organisations
- Imperial College London (Lead Research Organisation)
- University of Glasgow (Collaboration)
- St. Jude Medical (Collaboration)
- International Centre for Genetic Engineering and Biotechnology (Collaboration)
- German Cancer Research Center (Collaboration)
- Université Catholique de Louvain (Collaboration)
- GlaxoSmithKline (GSK) (Collaboration)
- University of Cape Town (Collaboration)
- UNIVERSITY OF DUNDEE (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- Lightpoint Medical (Collaboration)
- Johannes Gutenberg University of Mainz (Collaboration)
People |
ORCID iD |
| Jonathan Weber (Principal Investigator) |
Publications
Akthar S
(2015)
Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.
in Nature communications
Campos-Pires R
(2018)
Xenon is neuroprotective against blast traumatic brain injury in vitro
in British Journal of Anaesthesia
Campos-Pires R
(2018)
Xenon Protects against Blast-Induced Traumatic Brain Injury in an In Vitro Model.
in Journal of neurotrauma
Campos-Pires R
(2018)
Xenon treatment improves short-term and long-term outcomes in a rodent model of traumatic brain injury
in British Journal of Anaesthesia
Campos-Pires R
(2019)
Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice.
in British journal of anaesthesia
Campos-Pires R
(2016)
Argon: A Noble Foe for Subarachnoid Hemorrhage.
in Critical care medicine
Campos-Pires R
(2015)
Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.
in Critical care medicine
Campos-Pires R
(2018)
A Novel In Vitro Model of Blast Traumatic Brain Injury.
in Journal of visualized experiments : JoVE
Freeman D
(2022)
A Perspective on microneedle sensor arrays for continuous monitoring of the body's chemistry
in Applied Physics Letters
Howes PD
(2014)
Bionanotechnology. Colloidal nanoparticles as advanced biological sensors.
in Science (New York, N.Y.)
| Description | Turner - ICiC2 - Joint Committee on Vaccination and Immunisation (JCVI) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Asked to advise the Joint Committee on Vaccination and Immunisation (JCVI) which advises UK health departments on immunisation relating to influenza. |
| URL | https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19 |
| Description | Apollo Therapeutics Award |
| Amount | £280,000 (GBP) |
| Organisation | Apollo Therapeutics |
| Sector | Private |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 10/2018 |
| Description | Apollo Therapeutics Award |
| Amount | £539,000 (GBP) |
| Organisation | Apollo Therapeutics |
| Sector | Private |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 09/2017 |
| Description | BHF Project Grant |
| Amount | £296,000 (GBP) |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2015 |
| End | 11/2018 |
| Description | Basic Research Capability Enhancement Program |
| Amount | £18,392 (GBP) |
| Organisation | National Research Foundation of Korea |
| Sector | Academic/University |
| Country | Korea, Republic of |
| Start | 08/2015 |
| End | 08/2016 |
| Description | CASE PhD Award |
| Amount | £106,564 (GBP) |
| Funding ID | MR/N017757/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 03/2021 |
| Description | Confidence in Concept |
| Amount | £840,000 (GBP) |
| Funding ID | MC_PC_16046 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 02/2019 |
| Description | Confidence in Concept |
| Amount | £944,000 (GBP) |
| Funding ID | MC_PC_17162 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 02/2020 |
| Description | Confidence in Concept 3 |
| Amount | £800,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2015 |
| End | 09/2016 |
| Description | Confidence in Concept 4 |
| Amount | £900,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2016 |
| End | 02/2018 |
| Description | Developmental Pathway Funding Scheme |
| Amount | £650,810 (GBP) |
| Funding ID | MR/N027736/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2016 |
| End | 07/2018 |
| Description | Dickinson - ICiC 2 - MRC DPFS |
| Amount | £651,000 (GBP) |
| Funding ID | MR/N027736/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | Edwards - ICiC 2 - WT PS |
| Amount | £125,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | |
| Description | Fuchter - ICiC 2 - IBCOMP |
| Amount | $226,000 (USD) |
| Organisation | Michael J Fox Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | |
| Description | Grant Application |
| Amount | £950,000 (GBP) |
| Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | ICiC 2 - Cass - Horizon 2020 |
| Amount | £3,976,537 (GBP) |
| Organisation | European Union |
| Sector | Public |
| Country | European Union (EU) |
| Start | 01/2019 |
| End | 12/2022 |
| Description | ICiC 2 - Karadimitris - CAR-iNKT cell immunotherapy for HIV infection |
| Amount | £147,000 (GBP) |
| Organisation | amfAR, The Foundation for AIDS Research |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2021 |
| End | 08/2022 |
| Description | ICiC 2 - Karadimitris - CAR-iNKT cell immunotherapy for multiple myeloma |
| Amount | £250,000 (GBP) |
| Organisation | The Kay Kendall Leukaemia Fund |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2024 |
| Description | ICiC 2 - Karadimitris - Developing novel targeted immunotherapy for infant and childhood MLL-rearranged acute lymphoblastic leukaemia |
| Amount | £850,000 (GBP) |
| Organisation | Cancer Research UK |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2021 |
| End | 04/2024 |
| Description | ICiC 2 - Nowlan - UK Commonwealth Scholarship |
| Amount | £125,000 (GBP) |
| Funding ID | N/A |
| Organisation | British Council |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2018 |
| End | 10/2021 |
| Description | ICiC 2 - Peters - British Heart Foundation Project Grant |
| Amount | £296,235 (GBP) |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2015 |
| End | 11/2018 |
| Description | ICiC 2 - Peters - British Heart Foundation Project Grant |
| Amount | £250,075 (GBP) |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2016 |
| End | 09/2019 |
| Description | ICiC 2 - Peters - NHLI Independent Research Fellowship scheme |
| Amount | £40,000 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 07/2015 |
| End | 06/2016 |
| Description | ICiC 2 - Peters - NIHR Imperial BRC Cardiovascular Theme Project Grant |
| Amount | £166,123 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | |
| Description | ICiC 2 - Peters - NIHR Imperial BRC Cardiovascular Theme Project Grant |
| Amount | £135,000 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | |
| Description | ICiC 2 - Peters - Rosetrees Trust Interdisciplinary Prize |
| Amount | £250,000 (GBP) |
| Organisation | Rosetrees Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2017 |
| End | 05/2020 |
| Description | ICiC 2 - Peters - Rosetrees Trust Project Grant |
| Amount | £40,000 (GBP) |
| Organisation | Rosetrees Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 10/2019 |
| Description | ICiC 2 - Turner - MRC DPFS Scheme |
| Amount | £1,250,000 (GBP) |
| Funding ID | MR/S036954/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2019 |
| End | 12/2021 |
| Description | ICiC 2&3 - Bentley - NIHR i4i |
| Amount | £1,100,000 (GBP) |
| Funding ID | II-LA-1117-20008 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2019 |
| End | 01/2020 |
| Description | Imperial Innovations Proof of Concept Grant |
| Amount | £20,000 (GBP) |
| Organisation | Imperial Innovations |
| Sector | Private |
| Country | United Kingdom |
| Start | 02/2016 |
| End | 05/2016 |
| Description | Improved Biomarkers & Clinical Outcome Measures RFA - Michael J Fox Foundation |
| Amount | $226,000 (USD) |
| Organisation | Michael J Fox Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2016 |
| End | 03/2017 |
| Description | MRC DPFS |
| Amount | £286,000 (GBP) |
| Funding ID | MR/M025004/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2015 |
| End | 12/2016 |
| Description | NHLI Independent Research Fellowship |
| Amount | £20,000 (GBP) |
| Organisation | Imperial College London |
| Department | National Heart & Lung Institute (NHLI) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 07/2015 |
| End | 07/2016 |
| Description | Pathfinder |
| Amount | £125,000 (GBP) |
| Funding ID | 204337/Z/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 09/2018 |
| Description | Royal Brompton & Harefield NHS Foundation Trust Seed Funding |
| Amount | £19,010 (GBP) |
| Organisation | Royal Brompton & Harefield NHS Foundation Trust |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | Senior Research Fellowship |
| Amount | £1,667,327 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 02/2023 |
| Description | Snelgrove - ICiC 2 - AUKIA |
| Amount | £46,500 (GBP) |
| Funding ID | AUK-IG-2014-286 |
| Organisation | Asthma + Lung UK |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2014 |
| End | 03/2016 |
| Description | Snelgrove - ICiC 2 - VIPA |
| Amount | £85,200 (GBP) |
| Organisation | Wellcome Value in People Award |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 09/2016 |
| End | 10/2017 |
| Description | UK-India Educational Research Initiative |
| Amount | £78,000 (GBP) |
| Organisation | British Council |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 04/2020 |
| Description | Wellcome Trust Enhancement Grant |
| Amount | £100,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2015 |
| End | 10/2017 |
| Description | Wellcome Trust Pathfinder Award |
| Amount | £108,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2015 |
| End | 08/2016 |
| Title | Baum - ICiC2 - Method for high throughput screening for potential inhibitors of malaria parasite (Plasmodium falciparum) protein translation in vitro |
| Description | We have developed a cell free protein translation assay and optimised this to 384 well plate (and validated it) to screen for potential drugs that inhibit protein translation. The assay was validated with both known and unknown drugs. The assay is based on 384 well plate and use of a spectrofluorometer, detecting luminescence from a luciferase-derived protein, expression by a parasite cell free lysate. |
| Type Of Material | Technology assay or reagent |
| Provided To Others? | No |
| Impact | We are hoping this tool will enable us to source funding to undertake high throughput screening of novel antimalarials in collaboration with the University of Dundee. |
| Title | Baum - ICiC2 - Translation-Inhibition |
| Description | The program aimed to develop a drug screening assay based on a method of processing parasite lysate into an in vitro competent expression system that can then be used in a plate based (high throughput) screening assay, monitoring for fluorescence/luminescence. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Once developed the assay platform will provide a means to screen libraries of drugs for potential antimalarials that target protein translation. |
| Title | Cass - ICiC2 - Nanostars |
| Description | Gold/silver nanostars are excellent structures for performing surfaced enhanced Raman spectroscopy (SERS). The method involves coating polymer microprobe structures, originally designed for minimally invasive continuous glucose sensing, with the nanostars and using these for minimally invasive sensing of other metabolites in the interstitial fluid by SERS. For additional specificity and sensitivity the nanostars can be modified with aptamers |
| Type Of Material | Technology assay or reagent |
| Provided To Others? | No |
| Impact | This tool is still being developed and has not yet generated any published or otherwise reported impacts. |
| Title | Peters - ICiC2 - AFWT |
| Description | Matlab code developed to analyse electroanatomic mapping data from patients in atrial fibrillation undergoing cardiac ablation. It computes the phase of the signal to identify activations of significantly varying amplitude, windows the signal and computes wavefront trajectories across the mapping area so as to identify the nature of propagation and direction of originating source. |
| Type Of Material | Physiological assessment or outcome measure |
| Provided To Others? | No |
| Impact | None as yet |
| Description | Baum - ICiC2 - GlaxoSmithKline (GSK) |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | Our lab is developing the in vitro drug screening assay, validating its activity and then taking this to GSK to enable miniaturisation required for high throughput drug screening of libraries. |
| Collaborator Contribution | GSK is providing in-house expertise and resources for the miniaturisation of our assay (once completed) towards making it industry standard for screening. This will take the form of a short term (6 weeks to 2 months) visit by Dr. Hella Baumann from the Baum lab who will work with GSK scientists to complete the miniaturisation of the assay. |
| Impact | The collaboration involves parasitology (parasite culture), biochemistry (in vitro translation) and high throughput screening. At present there have been no outputs to report (it is still an active collaboration). No published papers or meeting abstracts. |
| Start Year | 2015 |
| Description | Cass - ICiC2 - PNG |
| Organisation | University of Glasgow |
| Department | School of Engineering Glasgow |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We designed the microprobe structures and had the necessary dies machined. |
| Collaborator Contribution | Prof Gadegaard then used the dies to injection mould the microprobes in poly(carbonate) producing replica structures |
| Impact | The first description was submitted as an abstract for Biosensors 2016 and will be presented as a poster at the conference in May this year. The injection moulded structures are also being used in the next phase of a NIHR funded clinical studies. Disciplines are: Chemistry, materials science, biomedical engineering |
| Start Year | 2015 |
| Description | Dickinson - ICiC2 - Mainz |
| Organisation | Johannes Gutenberg University of Mainz |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Sharing of knowledge and techniques on brain injury models & neuroprotection |
| Collaborator Contribution | Sharing of knowledge and techniques on brain injury models & neuroprotection. This collaboration was initiated prior to the ICiC award but is important to Dr Dickinson's ICiC2 project. |
| Impact | Crit Care Med. 2015 Jan;43(1):149-58. doi: 10.1097/CCM.0000000000000624. Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury. Campos-Pires R1, Armstrong SP, Sebastiani A, Luh C, Gruss M, Radyushkin K, Hirnet T, Werner C, Engelhard K, Franks NP, Thal SC, Dickinson R BNA Meeting Edinburgh April 2015 Poster Xenon provides short term & long term neuroprotection in an in vivo model of traumatic brain Injury Rita Campos-Pires, Scott Armstrong, Anne Sebastiani, Tobi Hirnet, Clara Luh, Konstantin Radyushkin, Serge Thal, Nicholas Franks, Robert Dickinson Mechanisms of Anaesthesia Conference, Bonn Germany June 17th 2015: Oral presentation Rita Campos-Pires Xenon provides short term & long term neuroprotection in an in vivo model of traumatic brain |
| Start Year | 2010 |
| Description | Elson - ICiC 2 - DKFZ |
| Organisation | German Cancer Research Center |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Fabrication of structured lighting system with hyperspectral imaging for data acquisition in vitro and in vivo. |
| Collaborator Contribution | Discussion of technical ideas for processing and evaluation of structured lighting data. |
| Impact | Conference paper submitted to MICCAI 2017. |
| Start Year | 2016 |
| Description | Gunn - ICiC2 - DBG & DJM |
| Organisation | Imperial College London |
| Department | Department of Computing |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Prof Gunn's group including Dr Philip Noonan (Department of Medicine) implemented and evaluated GEM software modified to use multiple Kinect v2 sensors for increased field of view motion tracking in a PET/CT scanner. |
| Collaborator Contribution | Dr Ben Glocker + Dr. Jiefei Ma (Department of Computing) developed the GEM software for augmented reality applications. They assisted in 3D printing phantoms used to enable successful stereo calibration of the Kinect sensors. |
| Impact | An oral presentation at the IEEE Medical Imaging Conference in San Diego with associated conference proceedings to be published. This collaboration involved computer sciences with medical physics and engineering. |
| Start Year | 2015 |
| Description | ICiC 2 - Baum - International Centre for Genetic Engineering and Biotechnology |
| Organisation | International Centre for Genetic Engineering and Biotechnology |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | 1. ICGEB, we are testing their developed compounds in our IVT assay 2. University of Cape Town, we are testing their developed compounds in our IVT assay 3. Dundee Drug Discovery Unit, we are enabling the transfer of our IVT technology to their drug screening unit for development to HTP screening. |
| Collaborator Contribution | 1. ICGEB, providing the drugs for testing 2. University of Cape Town, providing the drugs for testing 3. Dundee Drug Discovery Unit, approached us about turning our assay to HTP. |
| Impact | None yet |
| Start Year | 2017 |
| Description | ICiC 2 - Baum - International Centre for Genetic Engineering and Biotechnology |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | 1. ICGEB, we are testing their developed compounds in our IVT assay 2. University of Cape Town, we are testing their developed compounds in our IVT assay 3. Dundee Drug Discovery Unit, we are enabling the transfer of our IVT technology to their drug screening unit for development to HTP screening. |
| Collaborator Contribution | 1. ICGEB, providing the drugs for testing 2. University of Cape Town, providing the drugs for testing 3. Dundee Drug Discovery Unit, approached us about turning our assay to HTP. |
| Impact | None yet |
| Start Year | 2017 |
| Description | ICiC 2 - Baum - International Centre for Genetic Engineering and Biotechnology |
| Organisation | University of Dundee |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | 1. ICGEB, we are testing their developed compounds in our IVT assay 2. University of Cape Town, we are testing their developed compounds in our IVT assay 3. Dundee Drug Discovery Unit, we are enabling the transfer of our IVT technology to their drug screening unit for development to HTP screening. |
| Collaborator Contribution | 1. ICGEB, providing the drugs for testing 2. University of Cape Town, providing the drugs for testing 3. Dundee Drug Discovery Unit, approached us about turning our assay to HTP. |
| Impact | None yet |
| Start Year | 2017 |
| Description | ICiC 2 - Elson - Lightpoint |
| Organisation | Lightpoint Medical |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Evaluation of new surgical technology. Creating a surgical device position/pose detection system. |
| Collaborator Contribution | Provision of surgical technology, gamma detection and usability expertise. |
| Impact | Some conference publications. |
| Start Year | 2018 |
| Description | Moore - ICiC2 - Early node implant trial in Belgium |
| Organisation | Catholic University of Louvain |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | All background work of implant design and manufacturing. |
| Collaborator Contribution | Operational plans for implant procedures. |
| Impact | None yet - too early |
| Start Year | 2015 |
| Description | Peters - ICiC2 - SJM |
| Organisation | St. Jude Medical |
| Country | United States |
| Sector | Private |
| PI Contribution | St. Jude Medical provide us with access to their systems and code to work with clinical data acquired for our R&D purposes, from which our technical insights support both our thoughts and IP, and help with their understanding the needs of clinicians in front-line cardiac arrhythmia treatment. |
| Collaborator Contribution | St Jude Medical are a company (based in Boston, USA) who develop electroanatomic mapping systems for use in cardiac ablation therapy. In particular, they develop the EnSite Velocity mapping system currently used for a significant proportion of atrial catheter ablation cases at Hammersmith Hospital. For this project they provide early access to new commercial products and technical advice on their use. They also provide exclusive or limited access to some research-related technologies. The collaboration began prior to the ICiC award but is important in Prof Peters' ICiC2 project |
| Impact | None so far |
| Description | Snelgrove - ICiC1+2 - DrSH |
| Organisation | Imperial College London |
| Department | Department of Life Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Generation / provision of novel Leukotriene A4 hydrolase (LTA4H) modulators and recombinant LTA4H enzyme. Knowledge of LTA4H active site and Structure-Activity Relationship (SAR) studies. |
| Collaborator Contribution | Expertise in X-ray crystallography - conducted experiments and analysis. |
| Impact | Successful generation of X-ray crystallography structures of lead compounds bound within active site of LTA4H. These will form part of a manuscript currently in preparation. They were also part of an unsuccessful application to the Wellcome Trust seeding drug discovery scheme and will form part of an application to the MRC DPFS scheme. |
| Start Year | 2014 |
| Description | Snelgrove - ICiC1+2 - ProfCL |
| Organisation | Imperial College London |
| Department | National Heart & Lung Institute (NHLI) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We have utilised Professor Lloyd's models of allergic airways disease to test our LTA4H knock-out mice and LTA4H modulators. We conducted all experiments and analysis with some technical help from Professor Lloyd's group, |
| Collaborator Contribution | Professor Lloyd is a world leader in murine models of allergic airways disease. She has provided expertise and knowledge of the models and her group have provided technical assistance. |
| Impact | Successful application for an Asthma UK Innovations award. Studies also formed part of an unsuccessful application to the Wellcome Trust seeding drug discovery scheme and will form part of an application to the MRC DPFS scheme. These studies are the subject of a manuscript currently being finalized. |
| Start Year | 2013 |
| Title | A FORCE MEASUREMENT MECHANISM |
| Description | A force measurement mechanism comprises two force input members (105, 106), a pair of cantilever springs (101, 102), and a force measuring means (107). One portion of each cantilever spring is held by a first constraint means (103) and one portion of each cantilever spring is held by a second constraint means (104) with each cantilever spring having an unconstrained length between the first and second constraint means that is free to bend. The constraint means (103, 104) hold the cantilever springs (101, 102) in a parallel and spaced apart arrangement. The force input members (105, 106) are attached via the constraint means so that relative movement of the force input members bends the cantilever springs (101, 02), and the force measuring means (107) is arranged to measure force applied between the force input members. |
| IP Reference | US2018010972 |
| Protection | Patent application published |
| Year Protection Granted | 2018 |
| Licensed | Yes |
| Impact | A simple, sensitive instrument providing measure of hand grip force across a wide range, while allowing flexion of the sensor |
| Title | LYMPH NODE REPLACEMENT CONSTRUCT |
| Description | An implantable lymph node replacement construct (10) comprising a body (12) having a plurality of inlets (24,26) and a lesser number of outlets (30). The body (12) further having an internal structure defining a fluid communication path through the body (12) from the inlets (24,26) to the outlet or outlets (30). The internal structure of the body (12) comprises an inlet portion (38), a convergent portion (40) and an outlet portion (42) such that lymph received by the construct (10) at the inlets (24,26) is conveyed through the inlet portion (38) of the internal structure to the convergent portion (40) whereupon the lymph is combined before passing to the outlet or outlets (30). |
| IP Reference | WO2016083784 |
| Protection | Patent application published |
| Year Protection Granted | 2016 |
| Licensed | No |
| Impact | N/A |
| Title | Bentley - ICiC2 - gripAble |
| Description | We are testing it for efficacy in small numbers of patients |
| Type | Therapeutic Intervention - Medical Devices |
| Current Stage Of Development | Early clinical assessment |
| Year Development Stage Completed | 2016 |
| Development Status | Actively seeking support |
| Impact | Won NHS Innovation Prize and UK Stroke Forum Patients Carers and Public Involvement Prize |
| Title | Gunn - ICiC2 - Prototype Kinect v2 near mode sensor |
| Description | The system consists of a modified Microsoft Kinect v2 which is rigidly mounted inside the scanner bore of a PET/CT scanner. Software tracks the position of the subject's head using the 3D data provided by the Kinect v2. Currently we are acquiring 40 research PET/CT clinical brain scans with motion data to perform motion correction in the aim of reducing image blur. This is funded using a Medical Research Council Development Pathway Funding Scheme. |
| Type | Support Tool - For Fundamental Research |
| Current Stage Of Development | Refinement. Clinical |
| Year Development Stage Completed | 2015 |
| Development Status | Under active development/distribution |
| Impact | The software and techniques developed could be applied to other aspects of healthcare such as respiratory monitoring. |
| Description | Bentley - ICiC 2 + 3 - ESC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Presentation at conference |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://eurostroke.eu/esc-vienna-2015 |
| Description | Dickinson - ICiC 2 - BRAIN |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Brain & BrainPET, organised by the ISCBFM, address many of the controversial issues within the area of neuroscience research. 2015 will feature a state-of-the art scientific program and showcase novel discoveries and techniques with the goal of enhancing delegates' understanding of brain function under physiological and pathological conditions. Brain & BrainPET will feature acclaimed international experts, who will debate, discuss and analyse the most promising investigations in brain protection and neurodegeneration. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://brain.kenes.com/Documents/Poster%20Supplement.pdf |
| Description | Dickinson - ICiC2 - Gillespie Primary School, London |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Robert Dickinson is doing outreach activities with Gillespie Primary School in Highbury, north London with their innovative Lab13 Science Lab. He visited Lab13 with one of his PhD students where they talked about the brain and the body with pupils from Years 2, 4 and 6. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Dickinson - ICiC2 - Imperial Festival |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Research group participated in Imperial Festival (15,000 attendees, May 2016, May 2014 & May 2013) with Research Zone display. We participated in an event for Imperial College Alumni & Donors (November 2014) - see http://bit.ly/1w6K6Gi and most recently (March 2015) at in an event as part of the Imperial Fringe series that focussed on how and why scientists and doctors use animals in research see http://bit.ly/1xrwoKh. |
| Year(s) Of Engagement Activity | 2010,2013,2014,2015,2016 |
| URL | http://bit.ly/1w6K6Gi |
| Description | Edwards, A - ICiC2 - C4 & ITV |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Dr Andrew Edwards gave interviews to both Channel 4 on this project for pieces timed to coincide with Jim O'Neil's report on the economic cost of AMR (14th May 2015). He is now on an expert list for both companies to provide interviews as needed in the future. |
| Year(s) Of Engagement Activity | 2015 |
| Description | Edwards, A - ICiC2 - Twitter account |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Established a twitter account @bugsinblood - used this to highlight on-going work and related media interviews. |
| Year(s) Of Engagement Activity | 2017 |
| Description | Elson - ICiC2 - Presentation at Hyperspectral Imaging & Applications Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | Poster presentation at conference Hyperspectral Imaging & Applications Conference, Ricoh Arena, Coventry |
| Year(s) Of Engagement Activity | 2016 |
| Description | Elson - ICiC2 - The 4th International Conference on Biomedical Engineering and Biotechnology (ICBEB2015) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | The International Conference on Biomedical Engineering and Biotechnology (ICBEB) is an international meeting held once a year. This, the fourth International Conference on Biomedical Engineering and Biotechnology (ICBEB2015) will be held in Shanghai, China, during August 18th-21st, 2015, which has been organizing after ICBEB2014, ICBEB2013, and ICBEB2012 by the ICBEB Organizing Committee. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://2015.icbeb.org/ |
| Description | Elson - ICiC2 - The Optoelectronics Global Conference 2015, Shenzhen, China |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Annual event co-located with China International Optoelectronic Exposition in Shenzhen China. The aim of this conference is to foster interactions among broad disciplines in the optoelectronics family. |
| Year(s) Of Engagement Activity | 2015 |
| Description | Fuchter - ICiC2 - Imperial College Brain Sciences Division Away Day |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | A research talk by Dr Fuchter at the Imperial College Brain Sciences Division Away Day on his work (medicinal chemistry) to a non-specialist, but scientific audience. |
| Year(s) Of Engagement Activity | 2015 |
| Description | Gunn - ICiC2 - PN Imperial Festival |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Imperial Festival showcases work performed at Imperial to the public, Friends of Imperial, and any other interested attendees. Over 12,000 people attended the festival in 2015. P. Noonan assisted B. Glocker at the Imperial Festival showcasing the head tracking and augmented reality software to over 10,000 attendees from the general public and Friends of Imperial over 3 days in May 2015. |
| Year(s) Of Engagement Activity | 2015 |
| URL | https://www.imperial.ac.uk/be-inspired/festival/about/festival-2015/ |
| Description | ICiC 2&3 - Bentley - BioJapan Medical Industry Conference, Yokohama 2018 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Gripable presented at a major healthcare exhibition on behalf of UK Medcity in Biojapan 2018 |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.imperial.ac.uk/news/189528/academics-startups-lead-trade-mission-japan/ |
| Description | ICiC 2&3 - Bentley - Science Museum, Late Exhibition, July 2018 |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Gripable presented it's research and provided live demonstrations in a Science Museum exhibition of healthcare |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://imperialbrc.nihr.ac.uk/2018/08/02/gripable-exhibits-at-science-museum-lates-event/ |
| Description | ICiC 2&3 - Bentley Key Presentation at International Summit on International Summit on Serious Health Games, March 2018 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | This was a one day summit on health games with presentations by several international companies and research groups. |
| Year(s) Of Engagement Activity | 2018 |
| URL | http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/arc/eventssummary/event_30-1-... |
| Description | Moore - ICiC2 - webcast seminar for the Lymphatic Education and Research Network |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | No public disclosures can be made until the intellectual property is protected. However, Prof. Moore made a general mention of new technologies being developed to treat oedema in a webcast seminar for the Lymphatic Education and Research Network, a charity aiming to raise awareness of this and other lymphatic disorders. Attendees from around the globe asked questions via a chat box afterward. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://lymphaticnetwork.org/news-events/biomechanical-approach-lymphedema |
| Description | Nowlan - ICiC2 - Imperial Festival Prototype Sensor |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | A prototype of our fetal movement monitor and data from its use were displayed at the Imperial College Festival in 2015. This is the principal public outreach event for Imperial College where research projects in the college are displayed to the general public. Our display involved a prototype of the device that members of the public could handle and assess, as well as see data on its use and ask questions related to its function. Over 1000 people saw the display and the prototype. The exhibition triggered several inquiries as to the medical importance of fetal movement, and allowed the public to actually handle and even wear the monitor. Very positive feedback was received with several queries relating to the medical impact and subsequent and commercial availability of the device. |
| Year(s) Of Engagement Activity | 2015 |
| URL | https://www.imperial.ac.uk/be-inspired/festival/whats-on/ |
| Description | Posocco - ICiC2 - ELIMED Workshop, Italy |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Piero Posocco gave a presentation at the ELIMED workshop in Catania, Italy. The ELIMED project aims to demonstrate the validity of new approaches based on laser- driven ion sources for potential future applications in medical and other multidisciplinary fields, including hadrontherapy. In 2018, a User-oriented beam-line, ELIMAIA (ELI Multidisciplinary Applications of laser-Ion Acceleration) equipped with diagnostics and dosimetry end-points will be commissioned at the ELI-Beamlines facility in the Czech Republic with the main goal to perform proof-of-principle experiments, dosimetry measurements and radiation biology investigations at high repetition rate. The main goal of the 3rd ELIMED workshop is to strengthen the collaboration among the international research groups involved in this challenging project and gather new ideas, proposals and additional requirements from a broad community of users coming from different fields (Physics, Biology, Medicine, Chemistry, Material Science, etc.) interested in exploiting the availability of non-conventional (laser-driven) ion beams at ELI-Beamlines. |
| Year(s) Of Engagement Activity | 2016 |
| URL | https://agenda.infn.it/conferenceDisplay.py?confId=10978 |
| Description | Snelgrove - ICiC 2 - ATRDD |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that it will hold a Research and Development Day on April 24, 2017 in New York. The event will be hosted by members of Akari's executive leadership team and will feature presentations from investigators and independent scientific advisors. The meeting will cover three main areas: * Interim results from the ongoing phase 2 trial in paroxysmal nocturnal hemoglobinuria (PNH) will be presented by Dr Anita Hill, the lead investigator in the study. Dr Hill is a Consultant Haematologist and Honorary Clinical Associate Professor at Leeds Teaching Hospital, which is one of the world's largest treatment centers for PNH patients. * Results from the pre-clinical development program targeting new disease opportunities for our lead compound Coversin, focusing on its unique dual leukotriene B4 (LTB4)/C5 activity will be presented by Dr Robert Snelgrove, National Heart and Lung Institute, Imperial College London whose particular expertise lies in LTB4 and lung inflammation. * New data on the pre-clinical pipeline, including the once-weekly subcutaneous formulation of Coversin, will be presented by Professor Arne Skerra, Professor of Biological Chemistry at the University of Munich and Chairman of XL-protein GmbH. The presentation will be webcast simultaneously |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.akaritx.com/wp-content/uploads/2017/03/2017-03-17-RD-day-20173.pdf |
| Description | Snelgrove - ICiC 2 - ATS |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Welcome to Washington, DC for the 2017 American Thoracic Society International Conference. The conference, which is expected to draw more than 15,000 investigators, educators, and clinicians, is truly the destination for pediatric and adult pulmonary, critical care, and sleep medicine professionals at every level of their careers. The conference is all about learning, networking and connections. Because it engages attendees across many disciplines and continents, the ATS International Conference draws a large, diverse group of participants, a dedicated and collegial community that inspires each of us to make a difference in patients' lives, now and in the future. By virtue of its size - ATS 2017 features approximately 6,700 original research projects and case reports, 500 sessions, and 800 speakers - participants can attend sessions and special events from early morning to the evening. At ATS 2017 there will be something for everyone. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://conference.thoracic.org/program/resources/2017/virtual-final-program.pdf |
| Description | Snelgrove - ICiC 2 - ATS |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 16,000 members. |
| Year(s) Of Engagement Activity | 2015 |
| URL | https://www.atsjournals.org/doi/book/10.1164/ajrccm-conference.2014 |
| Description | Snelgrove - ICiC 2 - BALR |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | The British Association for Lung Research 2016 summer meeting entitled 'Fight the good fight: Host-pathogen interactions in the lung'. The meeting was held at the Edge conference venue at the University of Sheffield (27- 29th July). |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://medicine.dept.shef.ac.uk/news/index.php/2016/09/15/student-success-at-the-british-association... |
| Description | Snelgrove - ICiC 2 - BCI |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Interviewed by BioCentury Innovations for an article detailing the potential clinical implications of my research and risks of conventional LTA4H inhibitors. BioCentury Innovations identifies commercially promising translational science and assesses the next steps required to develop the technology. In this manner they provide Innovations audience in R&D, business development, academia and the venture capital community with an early lead on fresh science with investment potential |
| Year(s) Of Engagement Activity | 2015 |
| URL | https://www.biocentury.com/bc-innovations/targets-mechanisms/2015-12-03/lta4hs-pro-and-anti-inflamma... |
| Description | Snelgrove - ICiC 2 - BSI |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | The BSI's main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare. The BSI seeks to help British immunology accomplish the highest possible goals. To meet this objective, the BSI undertakes the following: Running innovative events in research, public engagement and education Promoting and disseminating research and good practice in immunology, translational medicine and vaccination Working with its members to develop the benefits of membership and the relevance of the Society Providing bursaries and grants Enhancing public awareness of immunology Influencing policy and decision makers Working with other societies |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.bsicongress.com/# |
| Description | Snelgrove - ICiC 2 - BTS |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited speaker at British Thoracic Society 2017 meeting. The Science and Research Committee organised an outstanding line up of speakers for the Meeting, which was of interest to all health professionals involved in the care of patients with respiratory disease, as well as to biomedical scientists working on lung disease. The symposia programme contained some outstanding international speakers who, together with national experts, informed delegates of the very latest advances in the clinical, translational and basic science of lung disease. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.brit-thoracic.org.uk/document-library/learning-hub/winter-meeting-2017/bts-winter-meetin... |
| Description | Snelgrove - ICiC 2 - CU |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | CARL's Distilling Workshop Program in the USA is the original distilling workshop, now in its 20th year. The Distilling Workshop is a two-day comprehensive primer with distillation techniques demonstrated on commercial-scale copper pot distilleries - presented jointly by Chris Gerling, Enology Extension Associate of Cornell University's Brewing & Vinification Laboratory; Alexander Plank of CARL Distilleries and Nicolas Haase of B&D Technologies - CARL Distilleries' Americas office. The course agenda of the Workshop will alternate between theoretical presentations and discussions, and practical demonstrations on Cornell University's distilling system consisting of two state-of-the-art 50 liter capacity copper pot stills with finishing plate columns. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://app.certain.com/profile/web/index.cfm?PKwebID=0x93725236e8&varPage= |
| Description | Snelgrove - ICiC 2 - ECFC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | The ECFS annual conference provides a forum for all with a common interest in CF to meet and discuss their latest findings. This series of conferences began as the European Working Group for Cystic Fibrosis (EWGCF) with the first official meeting being held in Stockholm in 1970. True to the original tradition of the EWGCF, each year the conference is held in a different European location and is usually of 3 days duration. The conference scientific programme is put together by an invited scientific committee and includes topics covering the entire spectrum of CF related issues. Invited experts from basic science, clinical and social care give presentations within plenary sessions, symposia, workshops, special interest groups, and meet the experts sessions. In addition an essential ingredient of the conference is the presentation of work following the submission of abstracts from all areas of interest in CF. These presentations illustrate the work being conducted in the multiple disciplines throughout the Scientific and Clinical CF Communities. |
| Year(s) Of Engagement Activity | 2016 |
| URL | https://www.ecfs.eu/basel2016 |
| Description | Snelgrove - ICiC 2 - ELRIG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited speaker at The European Laboratory Research & Innovation Group (ELRIG). This year's conference concentrated on topics that are breaking new ground in drug discovery research. The theme for this conference was "Cells as models of disease and new therapeutic agents". Under this umbrella they put together two tracks on Immunotherapy: oncology focused and non-oncology focused, as well as tracks on single-cell analysis and physiologically relevant cell models. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://elrig.org/downloads/ri17/ri17_programme_web.pdf |
| Description | Snelgrove - ICiC 2 - ERSLSC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | The ERS Lung Science Conference is at the forefront of basic and translational respiratory science and it is an essential event for budding respiratory researchers looking to boost their career. It offers a unique opportunity to network with peers from across the globe and will present cutting-edge abstracts on novel experimental lung research. The following features are organised every year: |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.ersnet.org/assets/static/path/documents/programme/LSC2018_programme_08.03.2018.pdf |
| Description | Snelgrove - ICiC 2 - LIG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | The BSI's London Immunology Group has organised a one-day meeting around the theme of immunotherapy and discussion on targeting the innate and adaptive immune systems. |
| Year(s) Of Engagement Activity | 2016 |
| URL | https://www.immunology.org/events/innate-versus-adaptive-new-targets-in-immunological-therapy |
| Description | Snelgrove - ICiC 2 - RIC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited presentation to new company at the Roche Innovation Centre |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.s-ge.com/en/article/news/20174-roche-kaiseraugst |
| Description | Stevens - ICiC 2 - BIM |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presented at the Bio-Inspired Materials 2016 Meeting. Based on the successful events held in 2012 and 2014 in Potsdam the scope of this conference was to provide an interdisciplinary platform for the discussion of novel developments and trends in the field of bio-inspired materials research. Accordingly, the whole spectrum of biological materials was covered. Topics encompassed the formation mechanisms as well as the characterization of complex-shaped and hierarchically structured multifunctional materials present in living nature. Based on this, a further key topic will be the consideration of these architectures as archetypes for the generation of novel functional materials with an expanded property spectrum. The conference will address bio-inspired materials based on organic and/or inorganic phases including their mechanical, optical, electronic and magnetic properties as well as actuated systems. Further discussions will be dedicated to materials, which display their function in contact with biological systems, e.g. tissues. Moreover, theoretical modelling of the formation, structure and properties of biological and bio-inspired materials will play a main role. The programme will comprise several invited plenary lectures as well as oral and poster presentations. The conference is supported by the priority programme 1420 (Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials) of the Deutsche Forschungsgemeinschaft (DFG). |
| Year(s) Of Engagement Activity | 2016 |
| URL | https://bioinspired2016.inventum.de/fileadmin/Tagungen/2016/02-EuroBio-inspired/Grafiken/Programmhef... |
| Description | Stevens - ICiC 2 - EK |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The 10th World Biomaterials Congress in Montreal is dedicated to pioneering biomaterials researchers across the past four decades who have enabled innovation in the field, delivering on emerging technologies for global medical solutions. |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://tech4pco.com/wbc2016/flipbook/WBC2016.pdf |
| Description | Stevens - ICiC 2 - HG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | HG delivered the following oral presentation: Quantum dot-based detection of a tuberculosis-specific transcript signature, Materials Research Society Spring Meeting, San Francisco (April 2015) |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://epub.knepperpress.com/publication/index.php?i=249474&m=0&l=&p=318&pre=&ver=html5 |
| Description | Stevens - ICiC 2 - ISN |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | On February 3rd - 5th, 2016, the California NanoSystems Institute (CNSI) at the University of California, Los Angeles (UCLA) will host the 2016 International Symposium on Nanobiotechnology entitled "Nanomedicine from discovery to clinical reality: therapeutics, delivery and imaging." The Symposium on Nanobiotechnology provides a forum for rigorous discussion of cutting edge science in the design, synthesis and fundamental study of nanotechnology and application in the areas of biology and medicine. Nanobiotechnology research encompasses an extremely diverse group of scientists working in the fields of physical sciences, life sciences and medicine. Fundamental research leads to translation of these findings into clinically applicable interventions, and this process will also be a focus of the meeting. The 10th annual Symposium on Nanobiotechnology will cover new materials for drug delivery and cellular interactions, sensors and diagnostics, and new imaging techniques, as well as biological interactions such as immunological responses and in vivo targeting abilities. World-renowned researchers are invited speakers and young scientists will be given the opportunity to contribute talks and posters. Where relevant, discussion will focus upon possible translational aspects and real world applications with an eye to the unsolved and unmet problems of the future that Nanobiotechnology researchers collectively can solve. |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://cnsi.ctrl.ucla.edu/nanobiotechnology/pages/speakers |
| Description | Stevens - ICiC 2 - PH |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | This four-day workshop will engage international experts in a lively scientific debate around the measurement of concentration of nanoparticle in media, their chemistry and the nature of critical interfaces. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://www.npl.co.uk/upload/pdf/20150420-24_np-workshop_agenda-v2.pdf |
| Description | Stevens - ICiC 2 - WBC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited talk at the the World Biomaterials Congress |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://tech4pco.com/wbc2016/flipbook/WBC2016.pdf |
| Description | Stevens - ICiC1 - HG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | HG delivered the following oral presentation: Quantum dot-based detection of a tuberculosis-specific transcript signature, Materials Research Society Spring Meeting, San Francisco (April 2015) |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://epub.knepperpress.com/publication/index.php?i=249474&m=0&l=&p=318&pre=&ver=html5 |
| Description | Turner - ICiC2 - ACSG |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | 15 parents of food allergic children |
| Year(s) Of Engagement Activity | 2012,2013,2014,2015 |
| URL | http://www.anaphylaxis.org.uk/events/support-group-map/ |